Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-019216
Filing Date
2017-07-27
Accepted
2017-07-27 18:30:42
Documents
1
Period of Report
2017-07-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3977
  Complete submission text file 0000899243-17-019216.txt   5344
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LILLY VENTURES FUND I, LLC 115 W. WASHINGTON STREET,STE 1680-SOUTH INDIANAPOLIS IN 46204
Business Address
Shanafelt Armen (Reporting) CIK: 0001656151 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38130 | Film No.: 17987400